Professionals Services Insights Community
About Offices Careers
Home / Insights / The FTC's Overreaching ...
PDF

December 07, 2016 | Law360

Todd A. Harrison Claudia A. Lewis

The FTC's Overreaching Regulation Of Homeopathic Drugs

1 min

Todd Harrison, Claudia Lewis, Michelle Jackson and Ashley Saba’s article, "The FTC's Overreaching Regulation Of Homeopathic Drugs," was published in Law360 on December 7, 2016. The article discusses the FTC’s new policy regarding homeopathic drugs.

Related Services

Practices

Related Insights

The FDA READI-Home Challenge: A New Initiative to Reduce Readmissions
The FDA READI-Home Challenge: A New Initiative to Reduce Readmissions

April 10, 2026

3min
When Science Moves Faster Than FDA Labeling Rules: Litigation Risk Intensifies
When Science Moves Faster Than FDA Labeling Rules: Litigation Risk Intensifies

March 30, 2026

4min
CPG Brands, Meet Your New P&L Line Item: Packaging EPR
CPG Brands, Meet Your New P&L Line Item: Packaging EPR

March 27, 2026

7min
View More

Recent News

Variety Spotlights Eight Venable Attorneys in Its 2026 Legal Impact Report
Variety Spotlights Eight Venable Attorneys in Its 2026 Legal Impact Report

April 08, 2026

2min
Ari Markenson Named to Law360’s 2026 Healthcare Editorial Advisory Board
Ari Markenson Named to Law360’s 2026 Healthcare Editorial Advisory Board

April 06, 2026

1min
Crain’s New York Business Names Ari Markenson a 2026 Notable Leader in Health Care
Crain’s New York Business Names Ari Markenson a 2026 Notable Leader in Health Care

April 06, 2026

2min
View More